FINCK BARBARA K 4/A
4/A · Forte Biosciences, Inc. · Filed May 16, 2022
Insider Transaction Report
Form 4/AAmended
FINCK BARBARA K
Director
Transactions
- Award
Stock Option (right to buy)
2022-03-16+4,166→ 4,166 totalExercise: $1.43Exp: 2023-03-16→ Common Stock (4,166 underlying)
Footnotes (2)
- [F1]This amended Form 4 is being filed to report an option grant inadvertently omitted from the Form 4 filed on March 18, 2022.
- [F2]Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. "Date of Grant" shall mean March 16, 2022.